Reading the Reproductive History: A New Lens on Early-Onset Heart Attack Risk in Women
A woman's menstrual and pregnancy history may carry as much cardiovascular signal as her lipid panel.
A new analysis of the VIRGO and NHANES databases links several reproductive milestones to the odds of early-onset acute myocardial infarction.
The study, published in the American Journal of Preventive Cardiology, found that menarche timing, pregnancy complications, hormone exposure, breastfeeding duration, and menopausal status each carried independent associations with MI risk.
For clinicians building a cardiovascular risk profile in female patients, the findings argue for a more detailed reproductive history than most visits currently allow.
What the Study Found
The case-control design compared 1,561 women from the VIRGO registry who had an acute MI between ages 18 and 55 with 1,561 demographically similar controls drawn from NHANES.
Case patients carried a heavier traditional risk burden at baseline, including higher rates of hypertension, hyperlipidemia, diabetes, and current smoking compared with controls.
Despite adjustment for these traditional risk factors, several reproductive variables remained independently associated with MI risk.
| Reproductive Factor | Adjusted OR (95% CI) | Direction |
|---|---|---|
| Early menarche (age <11 years) | 2.07 (1.56–2.73) | ↑ Risk |
| Female hormone use, any (excludes contraception/infertility treatment) | 1.99 (1.62–2.46) | ↑ Risk |
| Reached menopause | 1.82 (1.50–2.22) | ↑ Risk |
| Oral contraceptive use, 1–5 years | 1.67 (1.36–2.05) | ↑ Risk |
| Gestational diabetes | 1.65 (1.23–2.19) | ↑ Risk |
| First live birth at age ≥30 years | 0.50 (0.36–0.69) | ↓ Risk |
| Breastfeeding ≥1 month | 0.46 (0.38–0.56) | ↓ Risk |
| Current contraceptive use | 0.49 (0.32–0.76) | ↓ Risk |
How the Risk Signal Shifts Across the Reproductive Timeline
Early menarche, defined here as onset before age 11, carried more than double the odds of early MI and may reflect a longer cumulative exposure to adiposity and metabolic dysregulation.
Gestational diabetes appeared to flag a vascular and metabolic vulnerability that persists well beyond pregnancy.
Any history of female hormone use outside contraception or fertility treatment nearly doubled the odds of MI, though neither database captured the underlying formulation, dose, or indication.
On the protective side, breastfeeding for at least one month nearly halved the odds of early MI, an association the study authors tie to lactation's favorable effects on insulin sensitivity and HDL cholesterol.
Stratified analysis suggested the relevant risk factors shift across the reproductive timeline rather than acting uniformly.
In premenopausal women, early menarche, gestational diabetes, and any female hormone use carried the strongest associations with MI.
In women who had already reached menopause at the time of their MI, delayed first birth and one-to-five years of oral contraceptive use showed the strongest associations instead.
The study authors interpret this as evidence that early-life reproductive exposures may act over shorter time horizons, while later-life reproductive patterns may require longer latency before their cardiovascular signal emerges.
Menarche
Early onset (<11y) tracks with higher lifetime adiposity and metabolic risk.
Childbearing Years
OCP duration, gestational diabetes, and parity timing each leave a distinct signal.
Postpartum / Lactation
Breastfeeding ≥1 month favorably shifts insulin sensitivity and HDL.
Perimenopause
Hormone use history and contraceptive patterns carry forward into this window.
Menopause
Menopausal status itself is independently associated with higher MI odds.
Caveats Worth Carrying Into Practice
An accompanying commentary on the study highlighted important limits to interpretation.
The case-control design cannot establish causation, and neither database captured granular data on hypertensive disorders of pregnancy, a recognized cardiovascular risk enhancer in its own right.
Because obesity, hypertension, and diabetes can develop before, during, or long after pregnancy, their timing relative to reproductive events raises the possibility of reverse causation rather than a direct causal pathway.
Even so, the associations for early menarche and oral contraceptive duration persisted after adjustment for traditional risk factors, suggesting these particular exposures predate the onset of chronic disease in most women.
The commentary calls for prospective cohort studies that track cardiometabolic risk factor development relative to reproductive events in real time rather than reconstructing the sequence retrospectively.
Part of a Broader Pattern
This reproductive-history signal fits a growing body of evidence that pregnancy and the years surrounding it function as a physiologic stress test for future cardiovascular health.
A separate, large prospective cohort study of more than 174,000 women, published in Hypertension and summarized by the National Heart, Lung, and Blood Institute, found that blood pressure trajectories captured in just the first 20 weeks of pregnancy independently predicted new-onset hypertension for up to 14 years after delivery, even in women who never developed a hypertensive disorder of pregnancy.
Complementary research highlighted by the American College of Cardiology has linked adverse pregnancy outcomes, including gestational diabetes and new-onset hypertension during pregnancy, to measurable shifts in midlife glucose, hemoglobin A1c, and blood pressure, particularly among women who entered pregnancy with elevated body weight.
Taken together, these findings support folding a structured reproductive history into the same risk-enhancer framework already applied to family history and chronic inflammatory disease in current prevention guidelines.
Bringing It Into the Risk Assessment Visit
Most cardiovascular risk calculators do not prompt for reproductive history, leaving this information to be volunteered or overlooked entirely.
A short, structured set of questions can capture the highest-yield elements without meaningfully extending visit time.
| Domain | Question to Ask | Why It Matters |
|---|---|---|
| Menstrual history | Age at first period | Early menarche tracks with higher lifetime adiposity and metabolic risk |
| Pregnancy complications | History of gestational diabetes or hypertensive disorders of pregnancy | Markers of metabolic/vascular stress that can persist long after delivery |
| Parity timing | Age at first live birth | Delayed first birth (≥30y) was associated with lower odds in this cohort |
| Lactation | Breastfeeding duration | ≥1 month linked to a more favorable insulin and lipid profile |
| Hormonal exposures | Cumulative oral contraceptive duration; other hormone use | Duration and history, not just current use, carried independent signal |
| Menopausal status | Current reproductive or menopausal stage | Menopause itself was independently associated with higher MI odds |
A 43-year-old woman presents to the emergency department with exertional chest pressure and is found to have a non-ST-elevation myocardial infarction.
Her traditional risk factors are modest: she is a never-smoker with a normal lipid panel and blood pressure in the high-normal range.
A focused reproductive history reveals menarche at age 10, gestational diabetes during her only pregnancy, four years of oral contraceptive use in her twenties, two weeks of breastfeeding, and recent onset of menopausal symptoms.
Layering this history onto her risk assessment reframes a seemingly low-risk presentation into one carrying several independent reproductive risk markers, supporting a more aggressive secondary-prevention and statin strategy than her traditional risk score alone would suggest.
Reproductive history, spanning menarche timing, pregnancy complications, hormone exposure, breastfeeding duration, and menopausal status, carries an independent signal for early-onset MI risk in women and deserves a routine place in cardiovascular risk conversations.
These associations are observational and cannot yet be used to assign causation or to replace validated risk calculators.
Until prospective data clarify timing and mechanism, the most actionable step is simple: ask the questions, document the answers, and let a positive reproductive history nudge an otherwise borderline risk assessment toward earlier and more aggressive prevention.
References
- Reproductive History May Inform CV Prevention Strategies in Women. TCTMD. June 2026.
- Association of reproductive factors with acute myocardial infarction in young women: a VIRGO and NHANES case-control study. American Journal of Preventive Cardiology. 2026;Epub ahead of print.
- Early Pregnancy Blood Pressure Trajectories and Hypertension Years After Pregnancy. Hypertension. 2025;82(5):e75–e87.
- Blood Pressure Patterns in Early Pregnancy Tied to Hypertension Risk Up to 14 Years Later. National Heart, Lung, and Blood Institute. April 2025.
- Pregnancy Complications Contribute to Cardiovascular Risk for Overweight Women, Study Finds. American College of Cardiology. April 2025.
